ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

42
Analysis
Health Care • China
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
•16 Aug 2015 18:22

Best of Smartkarma: The Guest Editor's Cut #22

Welcome to the 22nd Edition of the Smartkarma [Guest] Editor's Cut, a weekly summary of the key themes and ideas of the last week's research on...

Logo
730 Views
Share
•09 Jul 2015 06:01

Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder

China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...

Share
•01 Jul 2015 22:01

China ADR Privatizations: The Challenges of Getting the Best Deal

The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...

Share
•21 Feb 2015 00:02

Opening of E-commerce Channel to Change China's Drug Market

Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...

Share
•05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
497 Views
Share
x